"At GE Healthcare, we are committed to developing products that help clinicians address the challenges they are confronted with every day through high image quality, wide bore and efficient workflow featured in the Discovery RT,” said Shelley Shih, general manager of FastWorks and RT of Molecular Imaging and Computed Tomography at GE Healthcare. “We are proud to offer Discovery RT with Max Field of View technology – enabling clinicians to perform a full view edge-to-edge image acquisition with specified skin line and hounsfield unit (HU) accuracy to help improve patient’s radiation treatment plan.”
The GE MR Radiation Oncology Suite is another addition to a complete a portfolio of radiation oncology solutions from GE Healthcare. The suite includes a full complement of coils, positioning devices and pulse sequences to get voxels the right size in treatment position that can improve accuracy for treatment planning. In addition to the MR oncology suite, the SIGNA PET/MR, which has been commercially available in the U.S. since November 2014, offers time-of-flight PET reconstruction with exceptional sensitivity to explore lower PET dose opportunities. The SIGNA PET/MR is available with MR Silenz, part of SilentScan, with zero TE capability. Zero TE allows development in the area of bone segmentation, which has potential uses for MR simulation.
Ad Statistics
Times Displayed: 22487
Times Visited: 455 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
GE Healthcare also offers ExAblate, an MR-guided focused ultrasound that delivers high intensity focused ultrasound that thermally ablates targeted tissue using magnetic resonance imaging system (MRI) to identify and target tumors while providing temperature monitoring of the treated tissue in real-time. Also on display at ASTRO, the Discovery PET/CT portfolio features advanced motion management and Q.Clear, an exclusive reconstruction engine that improves up to two times the quantitation accuracy (SUVmean) and image quality (SNR), aimed at a more accurate treatment response assessment. This combined portfolio, including the new Discovery RT, helps to address critical clinical and technology needs in radiation oncology.
*Discovery RT and MaxFOV are not yet CE marked. For countries that require CE-marking, these products cannot be placed on the market or put into service until they are made to comply with the Medical Device Directive requirements for CE marking. Not available for sale in all regions.
About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients.
Back to HCB News
